Today: 21 May 2026
IonQ stock today: IONQ slips after hours as South Korea 100‑qubit deal hits tape
30 December 2025
2 mins read

IonQ stock today: IONQ slips after hours as South Korea 100‑qubit deal hits tape

NEW YORK, December 29, 2025, 19:03 ET — After-hours

  • IonQ shares were down 1.6% in after-hours trading after the company detailed a South Korea quantum system delivery.
  • The company said its 100‑qubit Tempo system will be integrated with KISTI’s flagship supercomputing cluster.
  • Traders are watching contract timing and the next earnings update for clues on the pace of commercialization.

IonQ, Inc. shares fell 1.6% to $45.25 in after-hours trading on Monday after the quantum computing company said it had finalized an agreement to deliver a 100‑qubit system to South Korea’s Korea Institute of Science and Technology Information (KISTI).

The announcement matters because investors have pushed quantum stocks around on thin evidence of near-term revenue. On-premises system deliveries tied to national research programs can offer clearer milestones than cloud-only access.

IonQ said it will deliver a 100‑qubit “Tempo 100” quantum system and integrate it into KISTI‑6 (“HANGANG”), which it described as the country’s largest high-performance computing cluster. High-performance computing, or HPC, is a supercomputing setup used for large-scale research workloads.

The company said the project will create South Korea’s first onsite “hybrid quantum-classical” integration, meaning quantum hardware is connected to conventional computing resources so users can run workflows that mix both. IonQ said access will be provided via a secure private cloud for researchers, universities and enterprises, but it did not disclose financial terms.

“This is a defining moment for both IonQ and South Korea,” Chairman and CEO Niccolo de Masi said in the statement.

IonQ said KISTI will lead development and operation of the quantum computing service and research platform, and that KISTI identified IonQ as the primary quantum technology provider alongside Megazone Cloud. KISTI’s president, Dr. Sik Lee, said the platform is intended to support applications ranging from healthcare and finance to materials science.

Quantum computing stocks have been volatile into year-end, with a late-December surge followed by a multi-day pullback as investors took profits and holiday trading thinned, Investors Business Daily reported. The publication said IonQ was up about 10% year-to-date, compared with sharper gains for some peers, and noted that many pure-play names were well below their 52-week highs.

Shares of rival quantum firms were mixed in late trading, with D-Wave Quantum up about 3.4%, while Rigetti Computing and Quantum Computing Inc were modestly lower.

IonQ builds trapped-ion quantum computers and sells access to its systems through major cloud platforms, while also pursuing direct system deployments and networking projects.

In its most recent quarterly update, IonQ said third-quarter revenue rose 222% year-on-year to $39.9 million and it raised its full-year 2025 revenue outlook to $106 million to $110 million.

Investors will be looking for more detail on delivery timing, revenue recognition and whether the KISTI deployment translates into incremental bookings. In quantum computing, “qubit count” is a headline metric, but buyers also scrutinize error rates, uptime and how reliably systems can be used for real workloads.

The next scheduled catalyst is IonQ’s fourth-quarter results, with market calendars estimating a late-February report date, though IonQ has not confirmed its next earnings publication date, MarketBeat’s earnings page shows.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers
Previous Story

AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers

Synopsys stock closes higher as traders eye Dec. 30 lawsuit deadline and Fed minutes
Next Story

Synopsys stock closes higher as traders eye Dec. 30 lawsuit deadline and Fed minutes

Go toTop